Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5return2ozma@lemmy.world to News@lemmy.world – 593 points – 7 months agofortune.com154Post a CommentPreviewYou are viewing a single commentView all commentsShow the parent comment why the hell that level of inefficiency was tolerated. Patents, e.g. legal monopolies. Maybe fines and penalties for undercutting someone who holds a patent should be scrapped for nonprofit manufacturers of generics. Maybe profit should come second to the betterment of humanity.1 more...
why the hell that level of inefficiency was tolerated. Patents, e.g. legal monopolies. Maybe fines and penalties for undercutting someone who holds a patent should be scrapped for nonprofit manufacturers of generics. Maybe profit should come second to the betterment of humanity.1 more...
Patents, e.g. legal monopolies.
Maybe fines and penalties for undercutting someone who holds a patent should be scrapped for nonprofit manufacturers of generics.
Maybe profit should come second to the betterment of humanity.